Clinical Trials Insight: 700035286
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2008
At a glance
- Drugs ICT 111 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- Sponsors ImmunoCellular Therapeutics
- 15 Jul 2008 New trial record.
- 09 Jul 2008 This trial is expected to commence in late 2008, subject to FDA clearance.